Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
ONSIW was delisted on the 3rd of December, 2018.
7 hedge funds and large institutions have $46K invested in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
17% more funds holding
Funds holding: 6 → 7 (+1)
69% less capital invested
Capital invested by funds: $148K → $46K (-$102K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$598 |
| 2 |
VF
Virtu Financial
New York
|
+$506 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$920 |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$108 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $20K | – | – | – |
|
|
ACA
2
Avoro Capital Advisors
New York
| $12K | – | – | – |
|
|
MWNA
3
Marshall Wace North America
New York
| $6K | – | – | – |
|
|
MIM
4
Monashee Investment Management
Boston,
Massachusetts
| $3K | -$920 | -25,000 | Closed |
|
|
PC
5
PointState Capital
New York
| $3K | – | – | – |
|
|
VF
6
Virtu Financial
New York
| $1K | +$506 | +13,755 | New |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1K | +$598 | +16,241 | New |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$108 | -2,929 | -53% |
|
ONSIW Hedge Fund Activity: Q2 2018 in Review
7 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) for Q2 2018, worth a combined $46K — down 69% from $148K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ONSIW positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $598. The largest seller was Monashee Investment Management, exiting entirely with an estimated $920 sold.
- 7 institutional investors held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) as of Q2 2018, up from 6 in Q1 2018.
- Funds reported $46K of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 stock for Q2 2018, down 69% quarter-over-quarter.
- 2 funds opened new Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 positions in Q2 2018 and 1 closed out, a net change of +1 holder.
- The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 buyer in Q2 2018 was Susquehanna International Group, an estimated $598 added.
- The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 seller in Q2 2018 was Monashee Investment Management, an estimated $920 sold.
Based on aggregated 13F filings for Q2 2018.